drugset / Trial / NCT04065698
Pharmacokinetics and Safety of RV521 Formulations
NaSingle-groupOpen-labelOther
Summary
The main aims of the study are to assess the pharmacokinetics and safety of single doses of RV521 administered as two different formulations
Timeline
- Start
- 2019-08-13
- Primary completion
- 2019-09-02
- Completion
- 2019-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sisunatovir | Small molecule | 200 mg | Oral |